Patient-reported outcomes and subsequent management in atrial fibrillation clinical practice: Results from the Utah mEVAL AF program.
Brian ZengerMingyuan ZhangAnn LyonsThomas Jared BunchJames C FangRoger A FreedmanLeenhapong NavaravongJonathan P PicciniRavi RanjanJohn A SpertusJosef StehlikJeffrey L TurnerTom GreeneRachel HessBenjamin Adam SteinbergPublished in: Journal of cardiovascular electrophysiology (2020)
AF PROs in clinical practice identify highly-symptomatic patients, corroborating findings in more controlled, clinical trials. Increased AFSS score correlates with more aggressive clinical management, supporting the utility of disease-specific PROs guiding clinical practice.
Keyphrases
- clinical practice
- patient reported outcomes
- atrial fibrillation
- clinical trial
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- oral anticoagulants
- left atrial
- heart failure
- left atrial appendage
- peritoneal dialysis
- quality improvement
- randomized controlled trial
- coronary artery disease
- direct oral anticoagulants
- left ventricular
- venous thromboembolism
- open label
- phase iii